Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DEREK R SMITH

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1407869019
CMS profile
291148
Location
NORWICH, CT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$62,295.58

253 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Page 3 of 6; records 101–150 of 253 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DEREK R SMITH

NPI 1407869019 · CMS profile ID 291148

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

NORWICH, CT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 6; records 101–150 of 253 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1407869019?year=2022&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DEREK R SMITH, NPI 1407869019, CMS profile ID 291148. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 6; records 101–150 of 253 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1407869019?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). DEREK R SMITH, NPI 1407869019, CMS profile ID 291148. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 6; records 101–150 of 253 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1407869019?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
DEREK R SMITH, NPI 1407869019, CMS profile ID 291148, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 6; records 101–150 of 253 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1407869019?year=2022&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

253 matching records · $62,295.58 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 253 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 253.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novartis Pharmaceuticals Corporation $20.2408/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894388883 CMS
Teva Pharmaceuticals USA, Inc. $18.6508/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954431309 CMS
Celgene Corporation $13.8708/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932809801 CMS
Genentech USA, Inc. $21.5108/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950706137 CMS
Sunovion Pharmaceuticals Inc. $17.2708/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 921021613 CMS
Amneal Pharmaceuticals LLC $20.9908/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 956602225 CMS
ABBVIE INC. $29.5608/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891626153 CMS
Janssen Pharmaceuticals, Inc $12.9908/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885886081 CMS
UPSHER-SMITH LABORATORIES LLC $19.2107/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 912311143 CMS
GENZYME CORPORATION $13.0707/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938787079 CMS
ABBVIE INC. $19.9707/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891626151 CMS
Biogen, Inc. $19.0407/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923438213 CMS
Biogen, Inc. $26.3007/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923399473 CMS
Sunovion Pharmaceuticals Inc. $14.6807/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 921056163 CMS
Biogen, Inc. $3,256.5007/19/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923459795 CMS
Horizon Therapeutics plc $21.1107/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937698861 CMS
ABBVIE INC. $7.3507/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891626149 CMS
PFIZER INC. $20.4407/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949495751 CMS
Janssen Pharmaceuticals, Inc $12.8107/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885886051 CMS
Amneal Pharmaceuticals LLC $22.1107/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 956602221 CMS
Celgene Corporation $15.0507/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932809781 CMS
Biohaven Pharmaceutical Holding Company Ltd. $25.7507/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923737811 CMS
ABBVIE INC. $29.1707/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891626147 CMS
Amneal Pharmaceuticals LLC $23.2907/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 956602217 CMS
Sunovion Pharmaceuticals Inc. $11.3507/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 921097913 CMS
UPSHER-SMITH LABORATORIES LLC $12.3506/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 912307521 CMS
Biohaven Pharmaceutical Holding Company Ltd. $8.9506/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923737809 CMS
E.R. Squibb & Sons, L.L.C. $3,120.0006/28/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932809787 CMS
Horizon Therapeutics plc $23.2506/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937698859 CMS
Celgene Corporation $26.4706/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932809773 CMS
GENZYME CORPORATION $20.7906/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938787061 CMS
Biogen, Inc. $28.1206/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923415487 CMS
Biogen, Inc. $23.5006/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923406333 CMS
Biogen, Inc. $7.3506/22/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923410063 CMS
Biogen, Inc. $133.3806/22/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923410263 CMS
ABBVIE INC. $19.7706/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891626145 CMS
Novartis Pharmaceuticals Corporation $17.9406/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894388861 CMS
Biohaven Pharmaceutical Holding Company Ltd. $19.6506/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923737807 CMS
EMD Serono, Inc. $26.3006/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941528597 CMS
Avanir Pharmaceuticals, Inc. $30.2006/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 935960443 CMS
Janssen Pharmaceuticals, Inc $12.5006/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885886105 CMS
Teva Pharmaceuticals USA, Inc. $22.2006/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954431271 CMS
Celgene Corporation $60.0006/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932809777 CMS
Celgene Corporation $20.2706/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932809775 CMS
Novartis Pharmaceuticals Corporation $22.3806/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894388857 CMS
Genentech USA, Inc. $29.9606/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950770279 CMS
ABBVIE INC. $29.3906/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891626143 CMS
Sunovion Pharmaceuticals Inc. $13.4906/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 921071749 CMS
Janssen Pharmaceuticals, Inc $2,420.0006/01/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885885999 CMS
Janssen Pharmaceuticals, Inc $19.5206/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885886057 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $137,534.82 227
PY2020 $59,272.15 199
PY2021 $36,804.74 183
PY2022 $62,295.58 253
PY2023 $42,695.79 275
PY2024 $53,088.09 264
PY2025 $77,297.11 318

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $15,664.70 19
PY2024 Principal investigator $30,060.00 21
PY2023 Principal investigator $12,000.00 16
PY2022 Principal investigator $3,856.50 3
PY2021 Principal investigator $20,543.50 4
PY2020 Principal investigator $3,700.00 1
PY2019 Principal investigator $5,840.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

19 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Roche Products Limited $300.00 09/25/2025 Covered Recipient Teaching Hospital
Hartford Hospital
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211544595
Principal investigator 1 Roche Products Limited $300.00 09/25/2025 Covered Recipient Teaching Hospital
Hartford Hospital
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211544606
Principal investigator 1 Roche Products Limited $300.00 09/25/2025 Covered Recipient Teaching Hospital
Hartford Hospital
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211544623
Principal investigator 1 Roche Products Limited $300.00 07/03/2025 Covered Recipient Teaching Hospital
Hartford Hospital
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211544587
Principal investigator 1 Roche Products Limited $300.00 07/03/2025 Covered Recipient Teaching Hospital
Hartford Hospital
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211544591
Principal investigator 1 Roche Products Limited $300.00 07/03/2025 Covered Recipient Teaching Hospital
Hartford Hospital
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211544597
Principal investigator 1 Roche Products Limited $300.00 07/03/2025 Covered Recipient Teaching Hospital
Hartford Hospital
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211544602
Principal investigator 1 Roche Products Limited $300.00 07/03/2025 Covered Recipient Teaching Hospital
Hartford Hospital
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211544610
Principal investigator 1 Roche Products Limited $30.00 07/03/2025 Covered Recipient Teaching Hospital
Hartford Hospital
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211544614
Principal investigator 1 Roche Products Limited $300.00 07/03/2025 Covered Recipient Teaching Hospital
Hartford Hospital
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211544618
Principal investigator 1 Roche Products Limited $300.00 07/03/2025 Covered Recipient Teaching Hospital
Hartford Hospital
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211544626
Principal investigator 1 Roche Products Limited $300.00 07/03/2025 Covered Recipient Teaching Hospital
Hartford Hospital
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211544631
Principal investigator 1 GENZYME CORPORATION $10,534.70 05/19/2025 Covered Recipient Teaching Hospital
Hartford Hospital
A Randomized, Double-blind, Phase 3 Study Comparing Efficacy and Safety of Frexalimab (SAR441344) to Placebo in Adult Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis No dispute reported 06/30/2026 1226142811
Principal investigator 1 Roche Products Limited $300.00 04/03/2025 Covered Recipient Teaching Hospital
Hartford Hospital
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211544583
Principal investigator 1 Roche Products Limited $300.00 01/09/2025 Covered Recipient Teaching Hospital
Hartford Hospital
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211544563
Principal investigator 1 Roche Products Limited $300.00 01/09/2025 Covered Recipient Teaching Hospital
Hartford Hospital
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211544567
Principal investigator 1 Roche Products Limited $300.00 01/09/2025 Covered Recipient Teaching Hospital
Hartford Hospital
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211544570
Principal investigator 1 Roche Products Limited $300.00 01/09/2025 Covered Recipient Teaching Hospital
Hartford Hospital
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211544574
Principal investigator 1 Roche Products Limited $300.00 01/09/2025 Covered Recipient Teaching Hospital
Hartford Hospital
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211544578